Addition of exenatide twice daily to basal insulin for the treatment of type 2 diabetes: clinical studies and practical approaches to therapy

BACKGROUND: Type 2 diabetes is a progressive disease that requires stepwise additions of non-insulin and insulin therapies to meet recommended glycaemic goals. The final stage of intensification may require prandial insulin, adding complexity and increased risks of hypoglycaemia and weight gain. AIM...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobin, G S, Cavaghan, M K, Hoogwerf, B J, McGill, J B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549476/
https://www.ncbi.nlm.nih.gov/pubmed/23061886
http://dx.doi.org/10.1111/ijcp.12032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549476/
https://www.ncbi.nlm.nih.gov/pubmed/23061886
http://dx.doi.org/10.1111/ijcp.12032

Ejemplares similares